General Information of the Compound
Compound ID
CP0246542
Compound Name
N-benzyl-N-hydroxy-2,2-dimethylbutanamide
    Show/Hide
Synonyms
1956370-21-0
A1-28956
BDBM50229025
C(C1=CC=CC=C1)N(C(C(CC)(C)C)=O)O
CHEMBL4092421
CS-6266
EX-A4338
GTPL9643
HY-101032
MFCD30738006
N-benzyl-N-hydroxy-2,2-dimethylbutanamide
RIPA-56
SCHEMBL17874088
ZINC616570725
compound 56 [PMID: 27992216]
compound 92 [WO2016101885]
s6511
    Show/Hide
Structure
Formula
C13H19NO2
Molecular Weight
221.3
Canonical SMILES
CCC(C)(C)C(=O)N(O)Cc1ccccc1
    Show/Hide
InChI
InChI=1S/C13H19NO2/c1-4-13(2,3)12(15)14(16)10-11-8-6-5-7-9-11/h5-9,16H,4,10H2,1-3H3
    Show/Hide
InChIKey
AVYVHIKSFXVDBG-UHFFFAOYSA-N
Physicochemical Property
logP
2.8406
Rotatable Bonds
4
Heavy Atom Count
16
Polar Areas
40.54
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
16

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 121439991
ChEMBL ID
CHEMBL4092421
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05510, Receptor-interacting serine/threonine-protein kinase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000309 NCTC clone 929 Mus musculus (Mouse)  1
1
EC50 = 27 nM
   TI
   LI
   LO
   TS
Protein ID: PT00954, Receptor-interacting serine/threonine-protein kinase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000007 HT-29 Homo sapiens (Human)  1
1
EC50 = 28 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 13 nM
2 IC50 = 298 nM
Clinical Information about the Compound
Drug 1 ( RIPA-56 )
Drug Name RIPA-56
Company National Institute of Biological Sciences
Indication
Non-alcoholic fatty liver disease
Investigative
Target(s)
Receptor-interacting protein 1 (RIPK1)
Inhibitor